Cargando…
Surgical treatment for recurrent hepatocellular carcinoma: Current status and challenges
Primary liver cancer is the sixth most commonly diagnosed cancer and was the third leading cause of cancer deaths worldwide in 2020. It includes hepatocellular carcinoma (HCC) (representing 75%-85% of cases), intrahepatic cholangiocarcinoma (representing 10%-15% of cases), and other rare types. The...
Autores principales: | Wang, Di, Xiao, Min, Wan, Zhen-Miao, Lin, Xin, Li, Qi-Yong, Zheng, Shu-Sen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190723/ https://www.ncbi.nlm.nih.gov/pubmed/37206072 http://dx.doi.org/10.4240/wjgs.v15.i4.544 |
Ejemplares similares
-
Management of sub-centimeter recurrent hepatocellular carcinoma after curative treatment: Current status and future
por: Lee, Min Woo, et al.
Publicado: (2018) -
Evolution and current status of the subclassification of intermediate hepatocellular carcinoma
por: Yi, Peng-Sheng, et al.
Publicado: (2020) -
Immunotherapy for hepatocellular carcinoma: Current status and future perspectives
por: Mandlik, Deepa S, et al.
Publicado: (2023) -
Deep learning in hepatocellular carcinoma: Current status and future perspectives
por: Ahn, Joseph C, et al.
Publicado: (2021) -
Angiogenesis and immune checkpoint dual blockade: Opportunities and challenges for hepatocellular carcinoma therapy
por: Li, Si-Qi, et al.
Publicado: (2022)